Alcidion Group Limited (ASX: ALC) has announced a contract extension with South Tees Hospital NHS Foundation Trust for the continued use of its Miya Precision Electronic Patient Record (EPR) platform and Better OPENeP electronic prescribing and medicines administration (ePMA). Originally signed in November 2020 with an initial extension in December 2020, this new extension adds eight more years to the contract, making the total duration 10 years until 2033.
The minimum contract value for this period is AU$23.3 million, with AU$2.7 million allocated to the remaining two years of the existing contract. Additional options within the contract, such as PAS, Emergency Department, and Virtual Care modules, could potentially increase the contract value by AU$9.3 million (£4.9 million). The extension also includes options for a further 5-year extension to 2038, validating the value proposition of Alcidion's Miya Precision EPR solution in the NHS EPR market.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
